NAUTILUS BIOTECHNOLOGY, INC. (NAUT) Operating cash flow 2020–2025
NAUTILUS BIOTECHNOLOGY, INC. (NAUT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$50.7MFY2025 · since FY2020: -$14.0M → -$50.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.7M | +14.3% |
| FY2024 | -$59.1M | -14.4% |
| FY2023 | -$51.7M | -12.9% |
| FY2022 | -$45.8M | -16.7% |
| FY2021 | -$39.2M | -180.4% |
| FY2020 | -$14.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice